| 4 | Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia. (Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N) Blood Adv 2019 May 14;3(9):1499-1511 20 Citations |
| 1 | Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms. (Siatskas C, Underwood J, Ramezani A, Hawley RG, Medin JA) FASEB J 2005 Oct;19(12):1752-4 10 Citations |
| 1 | Thrombopoietic factors in chronic bone marrow failure states: the platelet problem revisited. (Kurzrock R) Clin Cancer Res 2005 Feb 15;11(4):1361-7 26 Citations |
| 1 | Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells. (Pivniouk VI, Snapper SB, Kettner A, Alenius H, Laouini D, Falet H, Hartwig J, Alt FW, Geha RS) Int Immunol 2003 Dec;15(12):1431-40 41 Citations |
| 1 | Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. (Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R) Cancer 2003 Dec 01;98(11):2410-9 21 Citations |
| 1 | Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. (Shaw PH, Olszewski M, Kletzel M) J Hematother Stem Cell Res 2001 Jun;10(3):391-403 11 Citations |
| 1 | Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. (Ferrajoli A, Talpaz M, Kurzrock R, Harris D, Van Q, Estey EH, Estrov Z) Leuk Lymphoma 1998 Jul;30(3-4):279-92 8 Citations |
| 1 | Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. (Estrov Z, Talpaz M, Mavligit G, Pazdur R, Harris D, Greenberg SM, Kurzrock R) Am J Med 1995 Jun;98(6):551-8 67 Citations |
| 1 | Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. (Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU, Kurzrock R) J Intern Med 1993 Oct;234(4):417-20 44 Citations |
| 1 | Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro. (Estrov Z, Kurzrock R, Talpaz M, Blake M, Gutterman JU) Ann Hematol 1991 Dec;63(6):297-301 12 Citations |
| 1 | Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. (Curtis BM, Williams DE, Broxmeyer HE, Dunn J, Farrah T, Jeffery E, Clevenger W, deRoos P, Martin U, Friend D) Proc Natl Acad Sci U S A 1991 Jul 01;88(13):5809-13 146 Citations |
| 1 | Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. (Kurzrock R, Talpaz M, Estrov Z, Rosenblum MG, Gutterman JU) J Clin Oncol 1991 Jul;9(7):1241-50 130 Citations |
| 1 | Cytokines in tumor therapy. Interleukin-3. (Kurzrock R, Estrov Z, Talpaz M, Gutterman JU) Am J Clin Oncol 1991;14 Suppl 1:S45-50 8 Citations |
| 1 | Biological molecules in the treatment of hematological disorders. (Kurzrock R, Talpaz M, Gutterman U) Sangre (Barc) 1989 Feb;34(1):53-8 |
© 2025 Clinical & Translational Science Institute